Cover Image
Market Research Report
Product code 
780441

NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services, Technology, Application, End User and Geography

Published: | The Insight Partners | 205 Pages | Delivery time: 1-2 business days

Price

Back to Top
NGS-Based RNA-Seq Market to 2027 - Global Analysis and Forecasts By Product & Services, Technology, Application, End User and Geography
Published: January 2, 2019
The Insight Partners
Content info: 205 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

In the report the NGS based RNA seq market, the market is expected to reach US$ 7,984.90 Mn in 2027 from US$ 1,414.59 in 2018. The market is estimated to grow with a CAGR of 19.3% from 2018-2027.

The NGS based RNA seq market is driven by the driving factor such as reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer However, the market is likely face the restraining factors such as risks related to genetic data and high cost of NGS instruments market. The future trend that is likely to drive the market growth is barcode scanning for long reads sequences.

The NGS based RNA seq market as per the product & services the segment is segmented as sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. The market of sequencing platform has the highest market share in 2018, contributing to NGS based RNA seq market is of 38.3% and is expected to retain its dominance during the forecast period from 2018 to 2027. The sample preparation segment is further sub-segmented into method and workflow step. The method segment further divided as manual and automated. Likewise, the workflow step is sub-segmented as Library preparation & target enrichment, fragmentation, end repair & size selection and quality control. Among the method segment the automated segment is likely to hold the major market in the forecast period. Similarly. The Library preparation & target enrichment among the workflow step segment.

The technology segment of the NGS based RNA seq market includes sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencings. The technology segment for the NGS based RNA seq market was valued at US$ 1,414.59 Mn in 2018 and is estimated to reach US$ 7,984.90 Mn by 2027. The technology segment and is expected to be the fastest growing segment in the forecast period owing advantages of the NGS-based RNA seq offers more sensible and accurate gene expression, the technologies can be applied to any species and these are available in comparatively less price for the various arrays. The companies offering offers various advantages to the researchers through their products. For instance, Illumina, Inc. offer system that uses sequencing by synthesis technology is being widely utilized across the globe for the next generation sequencing. The SBS technology enables the robust performance & maintains the data quality, provides accurate bases and more. Hence, owing to the advantages of the sequencing by synthesis by technology market is likely to propel in the forecast period

Some of the major primary and secondary sources included in the report NGS based RNA seq market are National Institutes of Health, National Science Foundation, Canada foundation for innovation, African Society of Human Genetics, Department of Biotechnology, Dubai Health Authority, Human Heredity and Health in Africa, French National Cancer Institute, Japan Science and Technology Agency, Trinity Translational Medicine Institute and others.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the NGS Based RNA Seq market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global NGS Based RNA Seq market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table of Contents
Product Code: TIPBT00002556

Table of Contents

1. INTRODUCTION 29

  • 1.1 SCOPE OF THE STUDY 29
  • 1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 29

2. GLOBAL NGS BASED RNA SEQ MARKET - KEY TAKEAWAYS 31

3. GLOBAL NGS BASED RNA SEQ MARKET - MARKET LANDSCAPE 34

  • 3.1 OVERVIEW 34
    • 3.1.1 Global NGS Based RNA Seq Market - By Product & Services 35
    • 3.1.2 Global NGS Based RNA Seq Market - By Technology 36
    • 3.1.3 Global NGS Based RNA Seq Market - By Application 36
    • 3.1.4 Global NGS Based RNA Seq Market - By End User 36
    • 3.1.5 Global NGS Based RNA Seq Market - By Geography 36
  • 3.2 PEST ANALYSIS 37
    • 3.2.1 North America PEST Analysis 37
    • 3.2.2 Europe PEST Analysis 39
    • 3.2.3 Asia Pacific PEST Analysis 41
    • 3.2.4 Middle East & Africa PEST Analysis 43
    • 3.2.5 South & Central America PEST Analysis 45

4. GLOBAL NGS BASED RNA SEQ MARKET - KEY MARKET DYNAMICS 47

  • 4.1 KEY MARKET DRIVERS 47
    • 4.1.1 Reduced Cost of Genome Sequencing 47
    • 4.1.2 Advancements in Sequencing Technology 47
    • 4.1.3 Next Generation Sequencing for Cancer 48
  • 4.2 KEY MARKET RESTRAINTS 48
    • 4.2.1 Risks Related to Genetic Data 48
    • 4.2.2 High Cost of NGS Instruments 49
  • 4.3 KEY MARKET OPPORTUNITIES 49
    • 4.3.1 Application of NSG in Biomarker Discovery and Precision Medicine 49
    • 4.3.2 Different Programs for RNA Sequencing 50
  • 4.4 FUTURE TRENDS 50
    • 4.4.1 Barcode Scanning for Long Reads Sequences 50
  • 4.5 IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS 51

5. NGS BASED RNA SEQ MARKET - GLOBAL ANALYSIS 52

  • 5.1 GLOBAL NGS BASED RNA SEQ MARKET REVENUE FORECASTS AND ANALYSIS 52
  • 5.2 GLOBAL NGS BASED RNA SEQ MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 53
  • 5.3 MARKET POSITIONING 54
  • 5.4 PERFORMANCE OF KEY PLAYERS 54
    • 5.4.1 Illumina, Inc. 54
    • 5.4.2 Thermo Fisher Scientific Inc. 55
  • 5.5 EXPERT OPINIONS 55

6. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY PRODUCT & SERVICES 56

  • 6.1 OVERVIEW 56
  • 6.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY PRODUCT & SERVICES, 2018 & 2027 (%) 56
  • 6.3 SAMPLE PREPARATION MARKET 57
    • 6.3.1 Overview 57
    • 6.3.2 Global Sample Preparation Market Revenue and Forecasts to 2027 (US$ Mn) 57
    • 6.3.3 Method Market 58
      • 6.3.3.1 Overview 58
      • 6.3.3.2 Manual Method Market 58
        • 6.3.3.2.1 Overview 58
        • 6.3.3.2.2 Global Manual Method Market Revenue and Forecasts to 2027 (US$ Mn) 59
      • 6.3.3.3 Automated Method Market 60
        • 6.3.3.3.1 Overview 60
        • 6.3.3.3.2 Global Automated Method Market Revenue and Forecasts to 2027 (US$ Mn) 60
    • 6.3.4 Workflow Step Market 61
      • 6.3.4.1 Overview 61
      • 6.3.4.2 Library Preparation & Target Enrichment Market 61
        • 6.3.4.2.1 Overview 61
        • 6.3.4.2.2 Global Library Preparation & Target Enrichment Market Revenue and Forecasts to 2027 (US$ Mn) 62
      • 6.3.4.3 Fragmentation, End Repair & Size Selection Market 63
        • 6.3.4.3.1 Overview 63
        • 6.3.4.3.2 Global Fragmentation, End repair & Size Selection Market Revenue and Forecasts to 2027 (US$ Mn) 63
      • 6.3.4.4 Quality Control Market 64
        • 6.3.4.4.1 Overview 64
        • 6.3.4.4.2 Global Quality Control Market Revenue and Forecasts to 2027 (US$ Mn) 64
  • 6.4 SEQUENCING SERVICES MARKET 65
    • 6.4.1 Overview 65
    • 6.4.2 Global Sequencing Services Market Revenue and Forecasts to 2027 (US$ Mn) 66
  • 6.5 SEQUENCING PLATFORM & CONSUMABLES MARKET 67
    • 6.5.1 Overview 67
    • 6.5.2 Global Sequencing Platform & Consumables Market Revenue and Forecasts to 2027 (US$ Mn) 68
  • 6.6 DATA ANALYSIS, STORAGE & MANAGEMENT MARKET 69
    • 6.6.1 Overview 69
    • 6.6.2 Global Data Analysis, Storage & Management Market Revenue and Forecasts to 2027 (US$ Mn) 69

7. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY TECHNOLOGY 70

  • 7.1 OVERVIEW 70
  • 7.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY TECHNOLOGY, 2018 & 2027 (%) 70
  • 7.3 SEQUENCING BY SYNTHESIS (SBS) MARKET 71
    • 7.3.1 Overview 71
    • 7.3.2 Global Sequencing By Synthesis (SBS) Market Revenue and Forecasts to 2027 (US$ Mn) 71
  • 7.4 NANOPORE SEQUENCING MARKET 72
    • 7.4.1 Overview 72
    • 7.4.2 Global Nanopore Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 72
  • 7.5 ION SEMICONDUCTOR SEQUENCING MARKET 73
    • 7.5.1 Overview 73
    • 7.5.2 Global Ion Semiconductor Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 73
  • 7.6 SINGLE MOLECULE REAL TIME (SMRT) SEQUENCING MARKET 74
    • 7.6.1 Overview 74
    • 7.6.2 Global Single Molecule Real Time (SMRT) Sequencing Market Revenue and Forecasts to 2027 (US$ Mn) 74

8. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY APPLICATION 75

  • 8.1 OVERVIEW 75
  • 8.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY APPLICATION, 2018 & 2027 (%) 75
  • 8.3 DIAGNOSTICS MARKET 76
    • 8.3.1 Overview 76
    • 8.3.2 Global Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn) 76
  • 8.4 DRUG DISCOVERY MARKET 77
    • 8.4.1 Overview 77
    • 8.4.2 Global Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn) 77
  • 8.5 PRECISION MEDICINE MARKET 78
    • 8.5.1 Overview 78
    • 8.5.2 Global Precision Medicine Market Revenue and Forecasts to 2027 (US$ Mn) 78
  • 8.6 OTHER APPLICATIONS MARKET 79
    • 8.6.1 Overview 79
    • 8.6.2 Global Other Applications Market Revenue and Forecasts to 2027 (US$ Mn) 79

9. GLOBAL NGS-BASED RNA-SEQ MARKET ANALYSIS - BY END USER 80

  • 9.1 OVERVIEW 80
  • 9.2 GLOBAL NGS-BASED RNA SEQ MARKET, BY END USER, 2018 & 2027 (%) 80
  • 9.3 HOSPITALS & CLINICS MARKET 81
    • 9.3.1 Overview 81
    • 9.3.2 Global Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn) 81
  • 9.4 RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES 82
    • 9.4.1 Overview 82
    • 9.4.2 Global Research Centers And Academic & Government Institutes Market Revenue and Forecasts to 2027 (US$ Mn) 82
  • 9.5 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET 83
    • 9.5.1 Overview 83
    • 9.5.2 Global Pharmaceutical & Biotechnology Companies Market Revenue and Forecasts to 2027 (US$ Mn) 83
  • 9.6 OTHER END USERS MARKET 84
    • 9.6.1 Overview 84
    • 9.6.2 Global Other End Users Market Revenue and Forecasts to 2027 (US$ Mn) 84

10. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 85

  • 10.1 OVERVIEW 85
  • 10.2 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 86
  • 10.3 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
    • 10.3.1 North America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 87
    • 10.3.2 North America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 87
  • 10.4 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
  • 10.5 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
  • 10.6 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
  • 10.7 NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 89
  • 10.8 US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 90
    • 10.8.1 US NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 90
    • 10.8.2 US NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 91
      • 10.8.2.1 US Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 91
      • 10.8.2.2 US Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 91
    • 10.8.3 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 92
    • 10.8.4 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 92
    • 10.8.5 US NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 93
  • 10.9 CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 94
    • 10.9.1 Canada NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 94
    • 10.9.2 Canada NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 95
      • 10.9.2.1 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 95
      • 10.9.2.2 Canada Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 95
    • 10.9.3 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 96
    • 10.9.4 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 96
    • 10.9.5 Canada NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 97
  • 10.10 MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 98
    • 10.10.1 Mexico NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 98
    • 10.10.2 Mexico NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 99
      • 10.10.2.1 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 99
      • 10.10.2.2 Mexico Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 99
    • 10.10.3 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 100
    • 10.10.4 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 100
    • 10.10.5 Mexico NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 101

11. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 102

  • 11.1 OVERVIEW 102
  • 11.2 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 103
  • 11.3 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
    • 11.3.1 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 104
    • 11.3.2 Europe Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 104
  • 11.4 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
  • 11.5 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
  • 11.6 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
  • 11.7 EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 106
  • 11.8 UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 107
    • 11.8.1 UK NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 108
    • 11.8.2 UK NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 108
      • 11.8.2.1 UK Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 109
      • 11.8.2.2 UK Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 109
    • 11.8.3 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 109
    • 11.8.4 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 110
    • 11.8.5 UK NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 110
  • 11.9 GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 111
    • 11.9.1 Germany NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 111
    • 11.9.2 Germany NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 112
      • 11.9.2.1 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 112
      • 11.9.2.2 Germany Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 112
    • 11.9.3 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 113
    • 11.9.4 Germany NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 113
    • 11.9.5 GERMANY NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 114
  • 11.10 FRANCE NEXT GENERATION SEQUENCING MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 115
    • 11.10.1 France NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 115
    • 11.10.2 France NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 116
      • 11.10.2.1 France Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 116
      • 11.10.2.2 France Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 116
    • 11.10.3 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 117
    • 11.10.4 France NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 117
    • 11.10.5 FRANCE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 118

12. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 119

  • 12.1 OVERVIEW 119
  • 12.2 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 120
  • 12.3 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
    • 12.3.1 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 121
    • 12.3.2 Asia Pacific Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 121
  • 12.4 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
  • 12.5 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
  • 12.6 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
  • 12.7 ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 123
  • 12.8 CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 124
    • 12.8.1 China NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 125
    • 12.8.2 China NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 125
      • 12.8.2.1 China Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 126
      • 12.8.2.2 China Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 126
    • 12.8.3 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 126
    • 12.8.4 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 127
    • 12.8.5 China NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 127
  • 12.9 INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 128
    • 12.9.1 India NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 129
    • 12.9.2 India NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 129
      • 12.9.2.1 India Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 130
      • 12.9.2.2 India Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 130
    • 12.9.3 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 130
    • 12.9.4 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 131
    • 12.9.5 India NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 131
  • 12.10 JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 132
    • 12.10.1 Japan NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 132
    • 12.10.2 Japan NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 133
      • 12.10.2.1 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 133
      • 12.10.2.2 Japan Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 133
    • 12.10.3 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 134
    • 12.10.4 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 134
    • 12.10.5 Japan NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 135

13. MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 136

  • 13.1 OVERVIEW 136
  • 13.2 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 137
  • 13.3 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 137
    • 13.3.1 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 138
    • 13.3.2 Middle East & Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 138
  • 13.4 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 139
  • 13.5 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 139
  • 13.6 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 140
  • 13.7 MIDDLE EAST & AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 140
  • 13.8 SAUDI ARABIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 141
    • 13.8.1 Saudi Arabia NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 141
    • 13.8.2 Saudi Arabia NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 142
      • 13.8.2.1 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 142
      • 13.8.2.2 Saudi Arabia Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 142
    • 13.8.3 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 143
    • 13.8.4 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 143
    • 13.8.5 Saudi Arabia NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 144
  • 13.9 UAE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 145
    • 13.9.1 UAE NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 145
    • 13.9.2 UAE NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 146
      • 13.9.2.1 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 146
      • 13.9.2.2 UAE Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 146
    • 13.9.3 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 147
    • 13.9.4 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 147
    • 13.9.5 UAE NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 148
  • 13.10 SOUTH AFRICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 149
    • 13.10.1 South Africa NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 149
    • 13.10.2 South Africa NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 150
      • 13.10.2.1 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 150
      • 13.10.2.2 South Africa Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 151
    • 13.10.3 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 151
    • 13.10.4 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 151
    • 13.10.5 South Africa NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 152

14. SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 153

  • 14.1 OVERVIEW 153
  • 14.2 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 154
  • 14.3 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 154
    • 14.3.1 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 155
    • 14.3.2 South and Central America Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 155
  • 14.4 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 156
  • 14.5 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 156
  • 14.6 SOUTH AND CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 157
  • 14.7 SOUTH & CENTRAL AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY COUNTRY (%) 157
  • 14.8 BRAZIL BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027 (US$ MN) 158
    • 14.8.1 Brazil NGS Based RNA Seq Market Revenue and Forecasts to 2027 (US$ Mn) 158
    • 14.8.2 Brazil NGS Based RNA Seq market Revenue And Forecasts to 2027, By Product & Services (US$ Mn) 159
      • 14.8.2.1 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Workflow (US$ Mn) 159
      • 14.8.2.2 Brazil Sample Preparation Market Revenue And Forecasts to 2027, By Method (US$ Mn) 159
    • 14.8.3 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Technology (US$ Mn) 160
    • 14.8.4 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By Application (US$ Mn) 160
    • 14.8.5 Brazil NGS Based RNA Seq Market Revenue And Forecasts to 2027, By End User (US$ Mn) 161

15. NGS-BASED RNA-SEQ MARKET -INDUSTRY LANDSCAPE 162

  • 15.1 OVERVIEW 162
  • 15.2 GROWTH STRATEGIES IN THE NGS-BASED RNA-SEQ MARKET, 2016-2018 162
  • 15.3 ORGANIC DEVELOPMENTS 162
    • 15.3.1 Overview 162
  • 15.4 ORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 163
  • 15.5 PRODUCT & SERVICE LAUNCH 163
    • 15.5.1 Recent Product & Service Launch By Players In The NGS-based RNA-seq Market 163
  • 15.6 PRODUCT APPROVAL 164
    • 15.6.1 Recent Product Approval By Players In The NGS-based RNA-seq Market 164
  • 15.7 OTHERS 164
    • 15.7.1 The NGS-based RNA-seq Market By Other Growth Strategies 164
  • 15.8 INORGANIC DEVELOPMENTS 165
    • 15.8.1 Overview 165
  • 15.9 INORGANIC GROWTH STRATEGIES IN THE MHEALTH MARKET, 2016-2018 165
  • 15.10 PARTNERSHIPS 166
    • 15.10.1 Recent Partnerships by Players in the NGS-based RNA-seq Market 166
  • 15.11 COLLABORATIONS 167
    • 15.11.1 Collaborations By Players In The NGS-based RNA-seq Market 167
  • 15.12 EXPANSION 168
    • 15.12.1 The NGS-based RNA-seq Market By Expansion 168
  • 15.13 ACQUISITIONS 169
    • 15.13.1 Acquisitions By Players In The NGS-based RNA-seq Market 169
  • 15.14 AGREEMENTS 169
    • 15.14.1 The NGS-based RNA-seq Market By Agreements 169

16. NGS-BASED RNA-SEQ MARKET-KEY COMPANY PROFILES 170

  • 16.1 ILLUMINA, INC. 170
    • 16.1.1 Key Facts 170
    • 16.1.2 Business Description 170
    • 16.1.3 Financial Overview 171
    • 16.1.4 Product Portfolio 171
    • 16.1.5 Swot Analysis 172
    • 16.1.6 Key Developments 172
  • 16.2 THERMO FISHER SCIENTIFIC INC. 174
    • 16.2.1 Key Facts 174
    • 16.2.2 Business Description 174
    • 16.2.3 Financial Overview 175
    • 16.2.4 Product Portfolio 175
    • 16.2.5 SWOT Analysis 176
    • 16.2.6 Key Developments 176
  • 16.3 PERKINELMER, INC. 177
    • 16.3.1 Key Facts 177
    • 16.3.2 Business Description 177
    • 16.3.3 Financial Overview 178
    • 16.3.4 Product Portfolio 178
    • 16.3.5 SWOT Analysis 179
    • 16.3.6 Key Developments 179
  • 16.4 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 180
    • 16.4.1 Key Facts 180
    • 16.4.2 Business Description 180
    • 16.4.3 Financial Information 180
    • 16.4.4 Product Portfolio 181
    • 16.4.5 SWOT Analysis 181
    • 16.4.6 Key Developments 181
  • 16.5 F. HOFFMANN-LA ROCHE LTD 182
    • 16.5.1 Key Facts 182
    • 16.5.2 Business Description 182
    • 16.5.3 Financial Information 183
    • 16.5.4 Product Portfolio 183
    • 16.5.5 SWOT Analysis 184
    • 16.5.6 Key Developments 184
  • 16.6 QIAGEN 185
    • 16.6.1 Key Facts 185
    • 16.6.2 Business Description 185
    • 16.6.3 Financial Information 186
    • 16.6.4 Product Portfolio 186
    • 16.6.5 SWOT Analysis 187
    • 16.6.6 Key Developments 188
  • 16.7 AGILENT TECHNOLOGIES 190
    • 16.7.1 Key Facts 190
    • 16.7.2 Business Description 190
    • 16.7.3 Financial Overview 191
    • 16.7.4 Product Portfolio 191
    • 16.7.5 SWOT Analysis 192
    • 16.7.6 Key Developments 192
  • 16.8 BGI 193
    • 16.8.1 Key Facts 193
    • 16.8.2 Business Description 193
    • 16.8.3 Financial Overview 193
    • 16.8.4 Product Portfolio 193
    • 16.8.5 SWOT Analysis 194
    • 16.8.6 Key Developments 194
  • 16.9 OXFORD NANOPORE TECHNOLOGIES 195
    • 16.9.1 Key Facts 195
    • 16.9.2 Business Description 195
    • 16.9.3 Financial Overview 195
    • 16.9.4 Product Portfolio 195
    • 16.9.5 SWOT ANALYSIS 196
    • 16.9.6 Key Developments 196
  • 16.10 EUROFINS SCIENTIFIC 197
    • 16.10.1 Key Facts 197
    • 16.10.2 Business Description 197
    • 16.10.3 Financial Overview 197
    • 16.10.4 Product Portfolio 198
    • 16.10.5 SWOT Analysis 198
    • 16.10.6 Key Developments 198

17. APPENDIX 199

  • 17.1 ABOUT THE INSIGHT PARTNERS 199
  • 17.2 GLOSSARY OF TERMS 200
  • 17.3 METHODOLOGY 202
    • 17.3.1 Coverage 203
    • 17.3.2 Secondary Research 203
    • 17.3.3 Primary Research 204

LIST OF TABLES

  • TABLE 1. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 86
  • TABLE 2. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 87
  • TABLE 3. NORTH AMERICA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 87
  • TABLE 4. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 88
  • TABLE 5. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 88
  • TABLE 6. NORTH AMERICA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 89
  • TABLE 7. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 91
  • TABLE 8. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 91
  • TABLE 9. US SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 91
  • TABLE 10. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 92
  • TABLE 11. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 92
  • TABLE 12. US NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 93
  • TABLE 13. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 95
  • TABLE 14. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 95
  • TABLE 15. CANADA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 95
  • TABLE 16. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 96
  • TABLE 17. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 96
  • TABLE 18. CANADA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 97
  • TABLE 19. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 99
  • TABLE 20. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 99
  • TABLE 21. MEXICO SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 99
  • TABLE 22. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 100
  • TABLE 23. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 100
  • TABLE 24. MEXICO NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 101
  • TABLE 25. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 103
  • TABLE 26. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 104
  • TABLE 27. EUROPE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 104
  • TABLE 28. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 104
  • TABLE 29. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 105
  • TABLE 30. EUROPE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 105
  • TABLE 31. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 108
  • TABLE 32. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 109
  • TABLE 33. UK SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 109
  • TABLE 34. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 109
  • TABLE 35. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 110
  • TABLE 36. UK NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 110
  • TABLE 37. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 112
  • TABLE 38. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 112
  • TABLE 39. GERMANY SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 112
  • TABLE 40. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 113
  • TABLE 41. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 113
  • TABLE 42. GERMANY NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 114
  • TABLE 43. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 116
  • TABLE 44. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 116
  • TABLE 45. FRANCE SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 116
  • TABLE 46. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 117
  • TABLE 47. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 117
  • TABLE 48. FRANCE NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 118
  • TABLE 49. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 120
  • TABLE 50. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 121
  • TABLE 51. ASIA PACIFIC SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 121
  • TABLE 52. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 121
  • TABLE 53. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 122
  • TABLE 54. ASIA PACIFIC NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 122
  • TABLE 55. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 125
  • TABLE 56. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 126
  • TABLE 57. CHINA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 126
  • TABLE 58. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 126
  • TABLE 59. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 127
  • TABLE 60. CHINA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 127
  • TABLE 61. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 129
  • TABLE 62. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 130
  • TABLE 63. INDIA SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (US$ MN) 130
  • TABLE 64. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY TECHNOLOGY (US$ MN) 130
  • TABLE 65. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY APPLICATION (US$ MN) 131
  • TABLE 66. INDIA NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY END USER (US$ MN) 131
  • TABLE 67. JAPAN NGS BASED RNA SEQ MARKET REVENUE AND FORECASTS TO 2027, BY PRODUCT & SERVICES (US$ MN) 133
  • TABLE 68. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY WORKFLOW (US$ MN) 133
  • TABLE 69. JAPAN SAMPLE PREPARATION MARKET REVENUE AND FORECASTS TO 2027, BY METHOD (U